AMERICAN SOCIETY FOR MICROBIOLOGY for AMERICAN SOCIETY FOR MICROBIOLOGY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Fiscal Year 2027 appropriations for NIH and CDC (H.R. 9260), NSF (H.R. 8845), DOE Office of Science (H.R. 9022), USDA research programs (H.R. 8646).
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMALIA CORBY-EDWARDS | — |
| NICHOLAS COX | — |
| JR KANE | — |
Science/Technology SCI
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676); Homestake AI Act of 2026 (S. 4991).
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMALIA CORBY-EDWARDS | — |
| NICHOLAS COX | — |
| JR KANE | — |
Agriculture AGR
Microbiome research impact on agricultural sciences.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS COX | — |
| JR KANE | — |
Health Issues HCR
Antimicrobial resistance; advanced molecular detection; national wastewater surveillance system (S.4048 - PREDICT Act); PAMA reform: RESULTS Act (H.R. 5269 S.2761); PASTEUR Act (H.R. 7352 and S. 4875); SUPER BUGS Act (H.R. 7879), and Stop Superbugs Act (S.5237).
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMALIA CORBY-EDWARDS | — |
| NICHOLAS COX | — |
| JR KANE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.